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Surviving preterm infants have a higher risk for infections in
the post-neonatal period (1,2). In order to evaluate the immune
status among preterm infants, we studied the gammaglobulin levels
in preterm infants of gestational age less than 31 weeks.
30 infants were studied whose gestational ages ranged between
23 to 31 weeks who were all appropriate for gestational age. Im-
munoglobulin levels were obtained every 2 weeks at post-natal ages
between 18 to 110 days. Infants were grouped according to their
IgG levels. Group I consisted of 15 infants with IgG less than
100mg.%; Group II consisted of 8 infants with IgG 100-200mg.%; and
Group III consisted of 7 infants with IgG 200-400mg.%.
TABLE I
Group I
(IgG<100)mg.%
n = 15
Birth Weight 887.3 ± 190
Gestational Age 26.46 ± 2.2
IgG (mg.%)
Post-Natal Age
Group II Group III
(IgG 100-200)mg.% (IgG 200-400)mg.%
50.82 ± 22.2
73.46 ± 18.82
n = 8
1126.2 ± 88
29 ± 1
162.2 ± 28.49
5.84
n = 7
1170 ±
30 ±
269.28 ±
24.71 ±
142...9
0.8
42
5.5235.35 ±
Between Group I and Group II statistically significant differences
(P less than 0.01) were noted among Birth Weight, Gestational Age,
IgG Levels and Post-Natal Age. Between Group II and III signifi-
cant differences were noted among IgG levels and Post-Natal Age
(P less than 0.01) .
Further, these infants were grouped again according to their
gestational age into 3 groups. Group I consisted of 6 infants with
gestational ages between 23 to 25. Group II consisted of 9 infants
with gestational ages of 26 to 28. Group III consisted of 15 in-
fants with gestational ages of 29 to 31.
TABLE II
Group I Group II
n=6 GA (23-25) n=9 GA (26-29)
701.66 ± 106 1000 ± 97.85
± 0.6 27.7 ± 0.66
58
21.6
Birth Weight
(Cms.)
Gestational Age 24
(weeks)
IgG (mg.%) .36.93 ± 14.6 92.46
Post-Natal Age 80.6 ± 2 4 . 6 57
(days)
Statistically significant differences were noted
between birth weights, gestational ages and IgG
and II. Between Groups II and III statistically
ferences were seen in birth weights, gestational
and post-natal age.
Group III
n=15 GA (29-31)
1153 ± 114.4
29.66 ± 0.81
192.77 ± 88.5
37.33 ± 18
(P less than 0.05)
levels in Groups I
significant dif-
ages, IgG levels
80
We further studied the cord blood levels and the percentage of
the drop of the gammaglobulin .levels .among 5 .infants.. The mean
birth weight of this group is 1018 ± 214gms. at a mean gestational
age of 28.2 ± 2.6 weeks. They had a mean percentage drop in the
.gammaglobulin levels from a cord blood IgG level of 72.99 ± 5.3%
by a mean post-natal age of 44.7 ± 12 days.
Our results indicate that infants born with extreme prematur-
ity tend to have significant and severe hypogammaglobulinemia.
The IgG levels in the fetus remain low until about the 17th
week of gestation (3). Afterwards, the levels increase propor-
tionately to the gestational age. At 40 weeks of gestation, the
IgG levels are about 5 to 10% higher than the maternal levels.
This is due to an active and passive component in the transfer of
IgG to the fetus from the Mother. Previous studies have demon-
strated a linear relationship between IgG levels and the gesta-
tional ages (4,5).
Our results indicate that infants with birth weights of less
than lOOOgms. are susceptible to extremely low levels of gammaglo-
bulin by approximately 2% months of post-natal age. It had been
reported that the post-neonatal mortality is high, -for infants dis-
charged from an intensive care nursery and infections accounted for
approximately 12% of the mortality among this group (6). We have
documented that extremely low birth weight infants have very low
levels of gammaglobulins by the time they are between 2 and 3
months of age. Whether these infants will benefit from gammaglo-
bulin administration is not known at present. We recommend moni-
toring gammaglobulin levels on all infants of less than 31 weeks
of gestational age prior to discharging from the intensive care
nursery and for further serial followup.
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